Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Assay:
≥98% (HPLC)
Form:
powder
Quality Segment
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear (warmed)
storage temp.
2-8°C
Application
Biochem/physiol Actions
MDMG-935P is a potent dual, noncompetitive inhibitor of glycolateoxidase (GO) and lactate dehydrogenase A (LDHA), targeting catalytic bindingsites with an IC50 of 9 µM for hLDHA and demonstrating robust in vitro oxalatereduction. It selectively modulates key pathways involved in oxalateoverproduction and upregulates fatty acid oxidation genes, such as CPT1α,showing significant efficacy in reducing liver triglycerides, oxalate levels,and hepatic fibrosis in MASH mouse models at an oral dose of 10 mg/kg. Invitro, Agxt1−/− mouse hepatocytes are employed to model primary hyperoxaluria,and HEK-293 cells are used to assess cytotoxicity. With its favorable metabolicstability, minimal toxicity, anti-fibrotic properties, oral bioavailability, and enhanced efficacy, MDMG-935P is an invaluable tool for investigatinghyperoxaluria and metabolic liver diseases.
Storage Class
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.